Aptinyx Inc. (APTX) Prices 6.4M Share IPO at $16/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Aptinyx Announces Pricing of Initial Public Offering
June 20, 2018 8:41 PM EDTEVANSTON, Ill., June 20, 2018 /PRNewswire/ -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the pricing of its initial public offering of 6,399,999 shares of its common stock at a public offering price of $16.00 per share. All of the shares are being offered by Aptinyx. In addition, Aptinyx has granted the underwriters a 30-day option to purchase 959,999 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.
... More


